Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 830M | 860M | 870M | 880M |
Cost of revenue | 380M | 310M | 400M | 380M |
Gross profit | 450M | 550M | 470M | 500M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 380M | 430M | 700M | 400M |
Other operating expenses | — | — | — | — |
Operating income | -310M | -250M | -590M | -260M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 110M | 110M | 110M | 110M |
Other income expense | — | — | — | — |
Pretax income | -340M | -730M | -560M | -290M |
Tax provision | 0 | 40M | 0 | 0 |
Net income | -25.6B | -25.0B | -23.8B | -22.9B |
Basic EPS | -9.3 | — | -8.7 | -8.3 |
Diluted EPS | -9.3 | — | -8.7 | -8.3 |
Basic average shares | 2.7B | — | 2.7B | 2.7B |
Diluted average shares | 2.7B | — | 2.7B | 2.7B |
EBITDA | 60M | 160M | -230M | 80M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |